Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients

被引：7
|
作者：
Sawai, Yusuke [1 ]
Yamanaka, Yuta [1 ]
Nomura, Shosaku [1 ]
机构：
[1] Kansai Med Univ, Dept Internal Med 1, 2-3-1 Shin Machi, Hirakata, Osaka 5731191, Japan
来源：
VASCULAR HEALTH AND RISK MANAGEMENT | 2020年 / 16卷
基金：
日本学术振兴会;
关键词：
factor XIII activity; cancer; thrombosis; endothelial cell; monocyte-derived microparticle; MDMP; MEAN PLATELET VOLUME; TISSUE-FACTOR; COAGULATION-FACTOR; VENOUS THROMBOEMBOLISM; IN-VIVO; RISK; LUNG; THROMBOSIS; RECOMMENDATIONS; DEFICIENCY;
D O I：
10.2147/VHRM.S240500
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Background: The aim was to evaluate factor XIII activity (FXIIIa) and monocyte-derived microparticles (MDMPs) in cancer patients. Methods: In total, 138 cancer patients (31 malignant lymphomas, 39 multiple myelomas, and 68 lung cancers) were analyzed. We measured various biomarkers including FXIIIa and MDMPs. Results: The values of endothelial activation markers, monocyte chemoattractant peptide (MCP)-1, soluble (s)CD14, and MDMPs were higher in cancer patients than in noncancerous controls. MCP-1, sCD14, and MDMPs were significantly correlated with FXIIIa in multivariate analysis in cancer patients. In addition, MCP-1, sCD14, and MDMP levels were significantly increased in the high FXIIIa group of patients. Finally, the survival rate of the high FXIIIa group was significantly poor in the Kaplan-Meier analysis. Conclusion: These results suggest that abnormal levels of FXIIIa and MDMPs may offer promise as poor prognostic factors in cancer patients.
引用
收藏
页码：103 / 110
页数：8
相关论文
共 50 条
  • [1] Monocyte-derived macrophage microparticles impart tissue factor activity to biomaterial surfaces
    Patchipulusu, Sirisha
    Turturro, Michael
    Hall, Connie L.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 92A (02) : 724 - 732
  • [2] Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer
    Kanazawa, S
    Nomura, S
    Kuwana, M
    Muramatsu, M
    Yamaguchi, K
    Fukuhara, S
    LUNG CANCER, 2003, 39 (02) : 145 - 149
  • [3] The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy
    Wang, Gui Hua
    Lu, Jian
    Ma, Kun Ling
    Zhang, Yang
    Hu, Ze Bo
    Chen, Pei Pei
    Lu, Chen Chen
    Zhang, Xiao Liang
    Liu, Bi Cheng
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2019, 26 (06) : 538 - 546
  • [4] Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus
    Omoto, S
    Nomura, S
    Shouzu, A
    Nishikawa, M
    Fukuhara, S
    Iwasaka, T
    DIABETOLOGIA, 2002, 45 (04) : 550 - 555
  • [5] Clinical significance of circulating microparticles for venous thromboembolism in cancer patients
    Thaler, J.
    Ay, C.
    Pabinger, I.
    HAMOSTASEOLOGIE, 2012, 32 (02): : 127 - 131
  • [6] Monocyte-derived microparticles stimulate alveolar macrophages from patients with sarcoidosis: modulation by PPARγ
    Amoruso, Angela
    Balbo, Piero E.
    Patrucco, Filippo
    Gavelli, Francesco
    Castello, Luigi M.
    Bardelli, Claudio
    Neri, Tommaso
    Celi, Alessandro
    Foci, Valentina
    Fresu, Luigia G.
    Brunelleschi, Sandra
    MINERVA BIOTECNOLOGICA, 2020, 32 (04) : 143 - 149
  • [7] Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPAR? ligands
    Bardelli, C.
    Amoruso, A.
    Canova, D. Federici
    Fresu, L. G.
    Balbo, P.
    Neri, T.
    Celi, A.
    Brunelleschi, S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (03) : 716 - 728
  • [8] Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles
    Ben-Hadj-Khalifa-Kechiche, Sonia
    Hezard, Nathalie
    Poitevin, Stephane
    Remy, Marie-Genevieve
    Florent, Bernadette
    Mahjoub, Touhami
    Nguyen, Philippe
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 30 (04) : 412 - 418
  • [9] Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles
    Sonia Ben-Hadj-Khalifa-Kechiche
    Nathalie Hezard
    Stephane Poitevin
    Marie-Geneviève Remy
    Bernadette Florent
    Touhami Mahjoub
    Philippe Nguyen
    Journal of Thrombosis and Thrombolysis, 2010, 30 : 412 - 418
  • [10] The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer
    Lwaleed, BA
    Chisholm, M
    Francis, JL
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 279 - 285
12345